TREATMENT PATTERNS AMONG LOWER-INCOME INDIAN PATIENTS WITH METASTATIC NON-SMALL CELL LUNG CANCER HARBORING EGFR MUTATIONS OR ALK REARRANGEMENTS

被引：2
|
作者：
Vashistha, Vishal
Garg, Avneet
Iyer, Hariharan
Jain, Deepali
Madan, Karan
Guleria, Randeep
Mohan, Anant
机构：
来源：
CHEST | 2020年 / 158卷 / 04期
关键词：
D O I：
10.1016/j.chest.2020.08.1621
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：1869A / 1869A
页数：1
相关论文
共 50 条
  • [1] Overall survival in patients with advanced non-small cell lung cancer harboring concomitant EGFR mutations and ALK rearrangements: A cohort study
    Zhou, Qing
    Yang, Jinji
    Zhang, Xuchao
    Chan, Huajun
    Su, Jian
    Tu, Hai-Yan
    Yan, Hong-Hong
    Wang, Zhen
    Xu, Chongrui
    Huang, Yisheng
    Jiang, Ben-Yuan
    Wang, Bin-Chao
    Bai, Xiao-Yan
    Wu, Yi-Long
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [2] Sequential treatment in advanced non-small cell lung cancer harboring EGFR mutations
    Hsu, Ping-Chih
    Chang, John Wen-Cheng
    Chang, Ching-Fu
    Huang, Chen-Yang
    Yang, Cheng-Ta
    Kuo, Chih-Hsi Scott
    Fang, Yueh-Fu
    Wu, Chiao-En
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2022, 16
  • [3] Sequential treatment in advanced non-small cell lung cancer harboring EGFR mutations
    Hsu, Ping-Chih
    Chang, John Wen-Cheng
    Chang, Ching-Fu
    Huang, Chen-Yang
    Yang, Cheng-Ta
    Kuo, Chih-Hsi Scott
    Fang, Yueh-Fu
    Wu, Chiao-En
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2022, 16
  • [4] EGFR Tyrosine Kinase Inhibitors for the Treatment of Metastatic Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Podcast
    Xiuning Le
    Eric Nadler
    Daniel B. Costa
    John Victor Heymach
    Targeted Oncology, 2023, 18 : 807 - 817
  • [5] Molecular Testing for EGFR Mutations and ALK Rearrangements in the Cytological Specimens From the Patients With Non-Small Cell Lung Cancer
    Wang, Xiaoyan
    Chen, Shaoxiong
    Emerson, Robert E.
    Wu, Howard H.
    Cramer, Harvey M.
    Curless, Kendra
    Chang, Hsim Yee
    Zhang, Shaobo
    Randolph, Melissa L.
    Cheng, Liang
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2019, 27 (02) : 119 - 124
  • [6] Postoperative management for non-small cell lung cancer harboring EGFR mutations
    Tanaka, Fumihiro
    Yoneda, Kazue
    Takenaka, Masaru
    JOURNAL OF THORACIC DISEASE, 2020, 12 (08) : 4556 - 4560
  • [7] Clinical outcome of treatment of metastatic non-small cell lung cancer in patients harboring uncommon EGFR mutation
    J. Chantharasamee
    N. Poungvarin
    P. Danchaivijitr
    S. Techawatanawanna
    BMC Cancer, 19
  • [8] Clinical outcome of treatment of metastatic non-small cell lung cancer in patients harboring uncommon EGFR mutation
    Chantharasamee, J.
    Poungvarin, N.
    Danchaivijitr, P.
    Techawatanawanna, S.
    BMC CANCER, 2019, 19 (1)
  • [9] Multicenter real-world data of patients harboring rare mutations other than EGFR or ALK in advanced or metastatic non-small cell lung cancer
    Lee, Su Yeon
    Kim, Young Chul
    Lee, Kye Young
    Lee, Sung Yong
    Lee, Shin Yup
    Lee, Min Ki
    Lee, Jeong Eun
    Jang, Seung Hun
    Jang, Tae-Won
    Choi, Chang Min
    THORACIC CANCER, 2022, 13 (03) : 380 - 385
  • [10] Lower Risk of Hypercoagulability in Non-Small Cell Lung Cancer Patients with EGFR Mutations
    Ohara, S.
    Suda, K.
    Takemoto, T.
    Nishino, M.
    Chiba, M.
    Fujino, T.
    Hamada, A.
    Koga, T.
    Soh, J.
    Misudomi, T.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S653 - S653
12345